| [1] |
郑荣寿，孙可欣，张思维，等.2015年中国恶性肿瘤流行情况分析[J]．中华肿瘤杂志，2019，41(1)：19-28.
|
| [2] |
VanCutsem E, Sagaert X, Topal B，et al.Gastric cancer[J]．Lancet，2016，388(10060)：2654-2664.
|
| [3] |
Wang YQ, Zhang QY, Weng WW，et al.Upregulation of the Non-Coding RNA OTUB1-isoform 2 Contributes to Gastric Cancer Cell Proliferation and Invasion and Predicts Poor Gastric Cancer Prognosis[J]. Int J Biol Sci，2016，12(5)：545-557.
|
| [4] |
Zhong JL, Huang CZ.Ubiquitin proteasome system research in gastrointestinal cancer[J]．World J Gastrointest Oncol，2016，8(2)：198-206.
|
| [5] |
Ni Q, Chen J, Li X，et al.Expession of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion[J]．Acta Biochim Biophys Sin (Shanghai)，2017，49(8)：680-688.
|
| [6] |
Zhou H, Liu Y, Zhu R，et al.OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability[J]. Oncogene，2018，37(25)：3356-3368.
|
| [7] |
Kim SY, Kwon SK, Lee SY，et al.Ubiquitin-specific peptidase 5 and ovarian tumor deubiquitinase 6A are differentially expressed in p53+/+ and p53-/- HCT116 cells[J]．Int J Oncol，2018，52(5)：1705-1714.
|
| [8] |
Inoue Y, Itoh Y, Sato K，et al.Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer[J]．Curr Cancer Drug Targets，2016，16(2)：110-118.
|
| [9] |
Messick TE, Russell NS, Iwata AJ，et al.Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein[J]．J Biol Chem，2008，283(16)：11038-11049.
|
| [10] |
Atanassov BS, Koutelou E, Dent SY.The role of deubiquitinating enzymes in chromatin regulation[J]．FEBS Lett，2011，585(13)：2016-2023.
|
| [11] |
孟小琴，李云峰，周毅，等．过表达OTUD1对结肠癌细胞HCT116增殖和侵袭的影响及机制研究[J]．重庆医科大学学报，2018，43(5)：687-691.
|
| [12] |
Yuan L, Lv Y, Li H，et al.DeubiquitylaseOTUD3regulates PTEN stability and suppresses tumorigenesis[J]．Nat Cell Biol，2015，17(9)：1169-1181.
|
| [13] |
Kim Y, Kim W, Song Y，et al.Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability[J]．Proc Natl Acad Sci USA，2017，114(18)：4691-4696.
|
| [14] |
Zhao B, Huang X, Zhang J，et al.Clinicopathologic factors associated with recurrence and long-term survival in node-negative advanced gastric cancer patients[J]．Rev Esp Enferm Dig，2019，111(2)：111-120.
|
| [15] |
Pan SW, Wang PL, Huang HW，et al.A Proposal of a Personalized Surveillance Strategy for Gastric Cancer：A Retrospective Analysis of 9191 Patients[J]．Gastroenterol Res Pract，2019，2019：3248727.
|
| [16] |
Zheng L, Wu C, Xi P，et al. The survival and the long-term trends of patients with gastric cancer in Shanghai，China[J]．BMC Cancer，2014，14：300.
|
| [17] |
陈东方，王新妹．影响胃癌根治术术后生存期的多因素分析[J]．中国现代医生，2018，56(13)：91-93.
|
| [18] |
金鑫，赵恩昊，曹晖，等．早期胃癌临床病理学特征与预后的关系[J]．外科理论与实践，2011，16(1)：58-62.
|
| [19] |
任磊，赵志鸿．进展期胃癌患者病理特征与预后相关因素分析[J]．现代医药卫生，2017，33(16)：2454-2456.
|
| [20] |
Hosoda K, Yamashita K, Katada N，et al.Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer[J]．Surg Today，2015，45(1)：68-77.
|
| [21] |
Wang X, Wan F, Pan J，et al.Tumor size：a non-neglectable independent prognostic factor for gastric cancer[J]．J Surg Oncol，2008，97(3)：236-240.
|
| [22] |
Huang CM, Xu M, Wang JB，et al.Is tumor size a predictor of preoperative N staging in T2-T4a stage advanced gastric cancer？[J]．Surg Oncol，2014，23(1)：5-10.
|